English(EN) MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimization

MolClaw 代理使用分层技能进行药物发现工作流程

作者 PulseAugur 编辑部 · [1 个来源] · 2026-04-27 04:00

研究人员推出 MolClaw，这是一种旨在简化药物分子发现、筛选和优化的自主代理。该代理利用具有 70 多种技能的分层技能架构，集成了 30 多个专业领域资源。MolClaw 在新推出的 MolBench 基准测试中表现出最先进的性能，该基准测试包括复杂的分子发现挑战。 AI

影响这种新代理可以通过自动化复杂的多步工作流程，显著加速药物发现流程。

排序理由详细介绍一种用于药物发现的新型 AI 代理的学术论文。

AI 生成摘要 · Google Gemini · 来自 1 个来源。我们如何撰写摘要 →

本文如何被排名

Signal score: 0 / 100; Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket: Research; 详细介绍一种用于药物发现的新型 AI 代理的学术论文。
Source corroboration: Single-source cluster; Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics: paper, product; Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance: High; Clearly on-topic for AI-industry coverage.
Story freshness: 175 days old; Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

完整方法见我们的编辑标准。

arXiv cs.AI TIER_1 English(EN) · Lisheng Zhang, Lilong Wang, Xiangyu Sun, Wei Tang, Haoyang Su, Yuehui Qian, Qikui Yang, Qingsong Li, Zhenyu Tang, Haoran Sun, Yingnan Han, Yankai Jiang, Wenjie Lou, Bowen Zhou, Xiaosong Wang, Lei Bai, Zhengwei Xie · 2026-04-27 04:00

MolClaw：一种具有分层技能的自主代理，用于药物分子评估、筛选和优化

arXiv:2604.21937v1 Announce Type: new Abstract: Computational drug discovery, particularly the complex workflows of drug molecule screening and optimization, requires orchestrating dozens of specialized tools in multi-step workflows, yet current AI agents struggle to maintain rob…